Researchers at Carnegie Mellon University have developed a groundbreaking lens technology that enables a camera to focus on ...
As of Monday, December 29, Aligos Therapeutics, Inc.’s ALGS share price has dipped by 5.24%, which has investors questioning ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
The latest update is out from Hansoh Pharmaceutical Group Company Limited ( ($HK:3692) ). Hansoh Pharmaceutical Group has signed a license ...
According to a Nature Communications report, the research was led by Jake Freedman and Matt Eichenfield, in collaboration ...
Abstract: We report a promising IQ optical modulator for beyond 100-GBd transmitter. By introducing both a new n-i-p-n heterostructure and an optimized capacitance-loaded traveling-wave electrode ...
A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...
This move represented a sharp increase in price on volume nearly 3x the average daily trading volume, indicating robust ...
Unidad de Gestión Clínica de Salud Mental, Instituto IBIMA, Hospital Regional Universitario, Málaga E-29010, Spain ...
Abstract: We present an automatic bias controller by completely using analog circuit with lower power consumption and smaller size compared to digital ones. Our controller maintains the bias point of ...
In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...
Clinical Trials Arena on MSN
Leads Biolabs and DNTH initiate trial of LBL-047 in SLE
The study has a two-part, placebo-controlled, double-blind, randomised, dose-escalation (single ascending dose) design.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback